Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL


Dr Lunning, DO, FACP, shares his impressions on the toxicity profile of axi-cel and liso-cel, and how he approaches treatment decision making for patients with relapsed-refractory (R/R) large B-cell lymphoma (LBCL).

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.